Drug trial offers hope for patients with hard-to-treat lung cancer in China, US
A new medication has shown promise as a safe and effective therapy for a hard-to-treat type of
lung cancer , according to an international clinical trial led by Chinese and US scientists.
Advertisement
The findings were published in the New England Journal of Medicine (NEJM) on April 28 and presented at the American Association for Cancer Research Annual Meeting in Chicago on the same day.
The researchers found that the oral medication zongertinib outperformed the standard treatment option when treating HER2-mutated non-small cell lung cancer (NSCLC). It works by targeting the HER2 protein and blocking the activity of the protein's tyrosine kinase, which is responsible for signalling cell growth.
This type of lung cancer is particularly difficult to treat. Unlike other NSCLC variants, it only has one treatment option that has been approved by the US Food and Drug Administration: intravenous antibody-drug conjugate (ADC) therapy. And ADC-class medications carry risks of adverse effects, including diarrhoea, nausea, fatigue and skin rashes.
Wang Xin, professor at the Chinese Academy of Medical Sciences Cancer Hospital, said in an April 29 review of the NEJM study that zongertinib had the 'potential to establish a new benchmark for targeted therapy in HER2-mutant NSCLC'.
10:51
New oral treatment for blood cancer offers 97% cure rate, Hong Kong researchers say
New oral treatment for blood cancer offers 97% cure rate, Hong Kong researchers say
The multi-cohort study was conducted at 82 sites around the world, including 18 US institutions, 17 in China and three in Japan. The analysis published by the NEJM included 188 NSCLC patients, with Asian populations accounting for a majority.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
5 hours ago
- South China Morning Post
New Chinese students barred from Harvard, how birds conquered skies: SCMP daily highlights
Catch up on some of SCMP's biggest China stories of the day. If you would like to see more of our reporting, please consider subscribing The administration of US President Donald Trump has formally barred Harvard University from enrolling international students, citing the institution's failure to address national security risks on campus. Russia's fresh bid to revive a strategic triangle with China and India as a counterbalance to the Western-led international order faces headwinds given the deep-seated distrust between the two Asian powers, according to observers. Fossils preserved in amber offer a unique opportunity to study soft structures, as objects stuck in the hardened tree resin remain trapped in time. Photo: AP/Science Dinosaur feathers found trapped in Burmese amber have shed new light on the evolution of flight feathers, an essential step that allowed early birds to surpass their dinosaur relatives in conquering the skies, a Chinese study has found.
South China Morning Post
6 hours ago
- South China Morning Post
US still reigns over China in tech race, but gaps are quickly closing: Harvard report
The United States continued to lead China in critical technologies, namely artificial intelligence (AI), biotechnology, semiconductors, space and quantum, according to a report released on Thursday by Harvard University. Advertisement The authors of the Critical and Emerging Technologies Index, released by the university's Belfer Centre for Science and International Affairs, said the US maintained its competitive edge because of large-scale American public and private investment, a top-notch and diverse research workforce, and a decades-old decentralised innovation ecosystem. To quantify the global tech race, the index assigned considerable weight to private and public funding resources – a US advantage not captured by trackers focusing on research output, such as the Nature Index and the Critical Technology Tracker, created by the Australian Strategic Policy Institute, both of which have pointed to China as the leading country in many research fields, according to the team. In January, Nature Index showed that in terms of high-quality scientific research output, Sichuan University, a regional university in southwest China, had overtaken Stanford University, the Massachusetts Institute of Technology, Oxford University and the University of Tokyo in less than two years. The index – maintained by the highly regarded academic journal, Nature – ranks research institutions based on their contributions to articles published in the world's most influential science journals. Advertisement
South China Morning Post
9 hours ago
- South China Morning Post
From NIH to SMART: senior biologist Lu Wei leaves US government post for China
Professor Lu Wei, a senior investigator at the US National Institutes of Health (NIH), is the latest Chinese academic to return home amid drastic funding cuts to university research grants by the Trump administration. He has taken up a full-time role with the Shenzhen Medical Academy of Research and Translation (SMART), as announced on the organisation's official social media account on June 3. SMART president Yan Ning reposted the announcement, commenting: '[Lu] officially agreed to come to Shenzhen long before President Donald Trump's second term. His research field is fascinating.' Lu has long focused on the neurobiological mechanisms of synaptic development and functional regulation, as well as the effects of anxiety, depression , anaesthesia and alcohol. Lu's relocation back to China significantly bolsters the ambitions of Shenzhen, an open economic special zone, to become a national centre for biomedical research. Lu graduated with a bachelor's degree in biochemistry from China's Sichuan University in 1997 and obtained a master's degree from Zhejiang University three years later.
